Table 3 Cardiovascular risk profile of patients with or without white matter hyperintensities (WMH) according to brain MRI
WMH* | ||||
|---|---|---|---|---|
No (n = 94) | Yes (n = 81) | p-value** | ||
≥1 stroke risk factor*** | No | 29 (30.9) | 19 (23.5) | 0.310 |
Yes | 65 (69.1) | 62 (76.5) | ||
Age; median (IQR) | 58 (52–64) | 64 (57–69) | < 0.001 | |
Female sex; n (%) | 29 (30.9) | 27 (33.3) | 0.747 | |
Congestive heart failure; n (%) | 6 (6.4) | 6 (7.4) | > 0.999 | |
Arterial hypertension; n (%) | 53 (56.4) | 47 (58.0) | 0.879 | |
Diabetes mellitus; n (%) | 8 (8.5) | 9 (11.1) | 0.615 | |
Peripheral artery occlusive disease; n (%) | 2 (2.1) | 2 (2.5) | > 0.999 | |
Coronary artery occlusive disease; n (%) | 15 (16.0) | 18 (22.2) | 0.335 | |
Hyperlipoproteinemia; n (%) | 43 (45.7) | 44 (54.3) | 0.290 | |
Paroxysmal AF; n (%) | 57 (60.6) | 61 (75.3) | 0.052 | |
Dilated left atrium according to echocardiography; n (%) | 39 (43.8) | 36 (47.4) | 0.754 | |
Left ventricular ejection fraction < 50%; n (%) | 5 (5.4) | 6 (7.6) | 0.756 | |